Azelex Cream
(Azelaic acid)ApprovedSmall molecule
Jazz PharmaceuticalsAzelaic acid is used to treat two common skin conditions: rosacea (reducing redness, swelling, and bumps on the face) and acne (clearing pimples and reducing swelling). It works by calming skin inflammation and killing bacteria that cause acne.[2] Azelex Cream is currently approved and in use across 3 indications[4].[1]
Azelex Cream is one of 42 small molecule programs targeting Central Centrifugal Cicatricial Alopecia. It is currently in Approved.
3
Indications
14
Total Trials
2
Active Trials
41
Competitors
3
FDA Applications
NDA/BLA/ANDA regulatory filings
4
Patents
Pipeline
Status by Indication[4][1]
Indication
Competition
Competitive Landscape
744 competitors in Breast Cancer
#DrugCompanyPhaseTrials
1Azelex Cream
Jazz PharmaceuticalsApproved
Vfend
PPrism Pharmaceuticals
Preclinical
Ablavar
LLantheus Medical Imaging
Preclinical
Naltrexone/bupropion
Novo NordiskPreclinical
Tc99m Sestamibi
MM.D. Anderson Cancer Center
Preclinical
Sertraline ODT
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Preclinical
Liposomal Irinotecan and Apatinib
SSecond Affiliated Hospital, School of Medicine, Zhejiang University
Preclinical
Tetracycline Hydrochloride
EEuropean Organisation for Research and Treatment of Cancer - EORTC
Preclinical
Midazolam Premedication
YYonsei University
Preclinical
Combination NRT
UUniversity of Alabama at Birmingham
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Rosacea9 trials
Show 6 more trials
Efficacy and Safety2 trials
Breast Cancer1 trial
Regulatory
FDA Approval Timeline[5]
Sep 13, 1995
AZELEX
NDA NDA020428
Dec 24, 2002
FINACEA
NDA NDA021470
Jul 29, 2015
FINACEA
NDA NDA207071
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Azelex Cream drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Azelaic acid. EMBL-EBI & Wellcome Sanger Institute.
- [5]
- [6]
- [7]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[3]
- Highest Phase
- Approved[1]
- Company